Key facts: Dassault Systemes SE Q3 €1.55B; ArisGlobal; Medidata leader
Dassault Systemes (DSY) reported Q3 revenue of €1.55B, up 5% YoY, with operating profit of €490M and margin of 31.6%. The company raised its 2026 revenue growth target to 4-5% and margin target to 32.5-32.7%. DSY also completed the acquisition of ArisGlobal, expecting strong multi-year growth, and Medidata was named a leader in IDC MarketScape 2026 for its AI-driven platform.
How this was made

The 30-second read
Why it matters
The earnings beat and acquisition are likely to drive short‑term buying interest, while longer‑term growth depends on integration success.
Market read
First‑report earnings and M&A news for a major European tech firm, providing fresh data for traders.
What to watch
Currency fluctuations (EUR/USD) and potential regulatory scrutiny of the acquisition in the EU.
Background
The article is a brief AI‑generated summary of Dassault Systèmes' Q3 results and its recent acquisition.
Ticker impact
Dassault Systèmes reported Q3 revenue of €1.55B (+5% YoY) and closed its acquisition of ArisGlobal, raising its 2026 guidance.
likely upward pressure as market prices in higher revenue and growth guidance.
Both the earnings numbers and the completed acquisition are fresh primary disclosures that improve growth outlook.
Market effects
Strengthens the life‑sciences software segment and may lift peers in the PLM/clinical‑trial software space.
European tech earnings boost sentiment for French and broader EU tech stocks.
Adds to the narrative of AI‑driven health‑tech growth worldwide.
Counterpoint
If integration costs of ArisGlobal exceed expectations, the guidance uplift could be overstated.
Key entities
- companyDassault Systèmes SE
French software giant listed on NYSE as DSY.
- companyArisGlobal
Life‑sciences software maker acquired by Dassault Systèmes.